首页 › 股票 › MPLT

MPLT — MAPLIGHT THERAPEUTICS INC

申报持仓市值$853.68M
持有基金数(最新)147
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)114
机构持仓市值$958.95M · 28.18M 股
新建/增持/减仓/清仓42 / 23 / 30 / 13 · 更新于 2026-11-14
前五大/前十大集中度48.8% / 66.3%
机构整体持仓变动 增持 +7.1% (+1.67M 股)
机构持仓市值变动 上升 +79.0%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 114 家机构在其最新 13F 申报中持有 MPLT(MAPLIGHT THERAPEUTICS INC),合计申报市值 $958.95M,对应 28.18M 股。按股数计算较上季度增持 7.1%(+1.67M 股),申报市值环比上升 79.0%。持仓集中度较高:前五大持有人占申报市值的 48.8%,前十大的集中度为 66.3%。

与上一季度相比,42 家新建仓位、23 家加仓、30 家减仓、13 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

MAPLIGHT THERAPEUTICS INC(MPLT)的主要机构持有人包括 Novo Holdings A/S、FCPM III SERVICES B.V.、T. Rowe Price Investment Management, Inc.,按 13F 申报市值在本页 147 家持有人中排名居前。

MPLT 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 59 11.42M $116.40M +42.1%
Q2 2026 114 28.18M $958.95M +7.1%
Q1 2026 85 25.16M $509.26M +8.4%
Q4 2025 77 23.43M $411.44M —

表内 4 个季度中,机构持股合计减少 51%(Q4 2025 → Q3 2026);单季变动最大的是 Q1 2026(+8.4%)。

前 25 大机构持仓人(Q3 2026) — 25 家基金

基金股数金额组合权重变化
Nan Fung Group Holdings Ltd 历史持仓 2.30M $23.44M 15.84% 增持
BlackRock Inc 1.71M $17.45M 0.00% 增持
Fidelity Management & Research (FMR) 1.54M $15.71M 0.00% 增持
Sanofi 历史持仓 912.04K $9.29M 1.48% 持有
Marshall Wace 612.31K $6.24M 0.01% 增持
Pivotal bioVenture Partners Investment Advisor LLC 历史持仓 611.45K $6.23M 2.54% 持有
Blue Owl Capital Holdings LP 历史持仓 556.37K $5.67M 1.07% 减持
Geode Capital Management 440.73K $4.49M 0.00% 增持
Capital World Investors 415.76K $4.24M 0.00% 持有
VANGUARD CAPITAL MANAGEMENT LLC 396.08K $4.04M 0.00% 减持
STATE STREET CORP 313.59K $3.20M 0.00% 减持
BNP PARIBAS FINANCIAL MARKETS 245.22K $2.50M 0.00% 增持
BNP Paribas Asset Management Holding S.A. 170.86K $1.74M 0.00% 持有
TD ASSET MANAGEMENT INC 140.89K $1.43M 0.00% 增持
VANGUARD PORTFOLIO MANAGEMENT LLC 120.87K $1.23M 0.00% 增持
VANGUARD FIDUCIARY TRUST CO 116.46K $1.19M 0.00% 减持
UBS Group AG 102.23K $1.04M 0.00% 减持
BARCLAYS PLC 85.81K $874.43K 0.00% 增持
HRT FINANCIAL LP 83.74K $853.00K 0.00% 增持
Manulife Financial 83.27K $848.56K 0.00% 增持
Quadrature Capital Ltd 74.48K $759.00K 0.01% 新进
Morgan Stanley 60.72K $618.70K 0.00% 增持
Citigroup Inc 59.17K $602.97K 0.00% 增持
Jump Financial, LLC 58.46K $595.72K 0.01% 增持
Nuveen, LLC 30.96K $315.45K 0.00% 增持

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 25 家基金

基金股数金额组合权重变化
Novo Holdings A/S 历史持仓 3.69M $132.13M 7.67% 持有
FCPM III SERVICES B.V. 历史持仓 3.23M $115.63M 15.41% 持有
T. Rowe Price Investment Management, Inc. 2.78M $99.70M 0.07% 减持
Goldman Sachs Group 1.95M $69.83M 0.02% 减持
PRICE T ROWE ASSOCIATES INC /MD/ 1.42M $51.00M 0.01% 增持
BlackRock Inc 1.03M $36.74M 0.00% 减持
Nan Fung Group Holdings Ltd 历史持仓 971.25K $34.81M 26.47% 持有
5AM Venture Management, LLC 历史持仓 950.01K $34.05M 11.83% 持有
Sanofi 历史持仓 912.04K $32.69M 6.12% 持有
Fidelity Management & Research (FMR) 823.56K $29.52M 0.00% 增持
VANGUARD CAPITAL MANAGEMENT LLC 784.15K $28.10M 0.00% 增持
Blue Owl Capital Holdings LP 历史持仓 729.93K $26.16M 4.22% 减持
Paradigm Biocapital Advisors LP 历史持仓 685.85K $24.58M 0.46% 新进
Pivotal bioVenture Partners Investment Advisor LLC 历史持仓 611.45K $21.91M 7.12% 持有
Velan Capital Investment Management LP 历史持仓 492.89K $17.67M 11.31% 持有
Siren, L.L.C. 450.00K $16.13M 0.33% 持有
Capital World Investors 415.73K $14.90M 0.00% 新进
Capital World Investors 415.73K $14.90M 0.00% 新进
GEODE CAPITAL MANAGEMENT, LLC 402.05K $14.41M 0.00% 新进
Geode Capital Management 402.05K $14.41M 0.00% 减持
BAKER BROS. ADVISORS LP 364.70K $13.07M 0.07% 持有
DAFNA Capital Management LLC 历史持仓 171.01K $6.13M 1.17% 持有
BNP Paribas Asset Management Holding S.A. 170.86K $6.12M 0.01% 减持
Freestone Grove Partners LP 168.91K $6.05M 0.04% 减持
Charles Schwab Investment Management 136.82K $4.90M 0.00% 减持

Q1 2026 — 25 家基金

基金股数金额组合权重变化
Novo Holdings A/S 历史持仓 3.69M $74.95M 6.07% 持有
FCPM III SERVICES B.V. 历史持仓 3.23M $65.59M 9.08% 持有
T. Rowe Price Investment Management, Inc. 2.80M $56.96M 0.04% 持有
Goldman Sachs Group 1.99M $40.56M 0.01% 增持
BlackRock Inc 1.34M $27.24M 0.00% 增持
Blue Owl Capital Holdings LP 历史持仓 1.01M $20.45M 6.30% 增持
Nan Fung Group Holdings Ltd 历史持仓 971.25K $19.75M 16.28% 持有
5AM Venture Management, LLC 历史持仓 950.01K $19.31M 5.36% 持有
Sanofi 历史持仓 912.04K $18.54M 5.52% 持有
VANGUARD CAPITAL MANAGEMENT LLC 719.82K $14.63M 0.00% 新进
Pivotal bioVenture Partners Investment Advisor LLC 历史持仓 611.45K $12.43M 4.44% 持有
Velan Capital Investment Management LP 历史持仓 492.89K $10.02M 6.28% 减持
Geode Capital Management 481.20K $9.79M 0.00% 增持
Siren, L.L.C. 450.00K $9.15M 0.25% 持有
Vestal Point Capital, LP 420.00K $8.54M 0.24% 增持
ADAR1 Capital Management, LLC 374.91K $7.62M 0.53% 新进
BAKER BROS. ADVISORS LP 364.70K $7.41M 0.04% 持有
STATE STREET CORP 339.12K $6.89M 0.00% 增持
Freestone Grove Partners LP 313.96K $6.38M 0.04% 增持
BNP Paribas Asset Management Holding S.A. 267.75K $5.44M 0.01% 增持
RA CAPITAL MANAGEMENT, L.P. 248.29K $5.05M 0.05% 新进
UBS Group AG 236.51K $4.81M 0.00% 增持
Fidelity Management & Research (FMR) 204.50K $4.16M 0.00% 增持
Board of Trustees of The Leland Stanford Junior University 199.23K $4.05M 0.48% 持有
SUPERSTRING CAPITAL MANAGEMENT LP 历史持仓 192.14K $3.91M 2.79% 新进

Q4 2025 — 25 家基金

基金股数金额组合权重变化
Novo Holdings A/S 历史持仓 3.69M $64.76M 5.03% 新进
FCPM III SERVICES B.V. 历史持仓 3.23M $56.67M 7.43% 新进
T. Rowe Price Investment Management, Inc. 2.80M $49.17M 0.03% 新进
Goldman Sachs Group 1.94M $34.03M 0.01% 新进
BlackRock Inc 1.10M $19.24M 0.00% 新进
Nan Fung Group Holdings Ltd 历史持仓 971.25K $17.06M 15.27% 新进
5AM Venture Management, LLC 历史持仓 950.01K $16.69M 5.25% 新进
Sanofi 历史持仓 912.04K $16.02M 5.16% 新进
Vanguard Group 869.67K $15.28M 0.00% 新进
Pivotal bioVenture Partners Investment Advisor LLC 历史持仓 611.45K $10.74M 4.15% 新进
PERCEPTIVE ADVISORS LLC 550.00K $9.66M 0.18% 新进
Velan Capital Investment Management LP 历史持仓 522.30K $9.17M 5.40% 新进
Siren, L.L.C. 450.00K $7.90M 0.24% 新进
Geode Capital Management 389.03K $6.83M 0.00% 新进
Vestal Point Capital, LP 385.00K $6.76M 0.23% 新进
BAKER BROS. ADVISORS LP 364.70K $6.41M 0.04% 新进
Jain Global LLC 327.69K $5.76M 0.06% 新进
Blue Owl Capital Holdings LP 历史持仓 327.06K $5.74M 1.77% 新进
STATE STREET CORP 229.48K $4.03M 0.00% 新进
Lazard Asset Management 207.49K $3.64M 0.01% 新进
LAZARD ASSET MANAGEMENT LLC 207.49K $3.64M 0.01% 新进
Board of Trustees of The Leland Stanford Junior University 199.23K $3.50M 0.70% 新进
Citadel Advisors 190.14K $3.34M 0.00% 新进
Freestone Grove Partners LP 183.77K $3.23M 0.02% 新进
Tetragon Partners GP Ltd 164.53K $2.89M 0.61% 新进

查看全部 147 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025
Nan Fung Group Holdings Ltd 2.30M 971.25K 971.25K 971.25K
BlackRock Inc 1.71M 1.03M 1.34M 1.10M
Fidelity Management & Research (FMR) 1.54M 823.56K 204.50K 904
Sanofi 912.04K 912.04K 912.04K 912.04K
Marshall Wace 612.31K 5.80K — 39.66K
Pivotal bioVenture Partners Investment Advisor LLC 611.45K 611.45K 611.45K 611.45K
Blue Owl Capital Holdings LP 556.37K 729.93K 1.01M 327.06K
Geode Capital Management 440.73K 402.05K 481.20K 389.03K
Capital World Investors 415.76K 415.73K — —
VANGUARD CAPITAL MANAGEMENT LLC 396.08K 784.15K 719.82K —
STATE STREET CORP 313.59K — 339.12K 229.48K
BNP PARIBAS FINANCIAL MARKETS 245.22K 70.48K 37.30K 3.46K
BNP Paribas Asset Management Holding S.A. 170.86K 170.86K 267.75K 147.93K
TD ASSET MANAGEMENT INC 140.89K 54.53K 47.77K 36.96K
VANGUARD PORTFOLIO MANAGEMENT LLC 120.87K 96.76K 112.60K —
VANGUARD FIDUCIARY TRUST CO 116.46K 123.14K 131.23K —
UBS Group AG 102.23K 122.03K 236.51K 18.29K
BARCLAYS PLC 85.81K 12.97K 5.79K 26.41K
HRT FINANCIAL LP 83.74K 51.98K — —
Manulife Financial 83.27K 7.04K — —

下载持有人名单 (CSV)

常见问题

Which funds hold MPLT?

As of 2026-Q2, 114 institutional funds reported holding MPLT (MAPLIGHT THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $958.95M.

How many shares of MPLT do institutions own?

13F filers reported 28.18M shares of MPLT, worth $958.95M in aggregate at the end of 2026-Q2.

Is institutional ownership of MPLT rising or falling?

Share counts moved +7.1% versus the prior quarter — accumulation.

Who are the top institutional holders of MPLT?

The largest 13F holders are Novo Holdings A/S, FCPM III SERVICES B.V., T. Rowe Price Investment Management, Inc., Goldman Sachs Group, PRICE T ROWE ASSOCIATES INC /MD/; the top 25 are ranked at the top of this page.

Who are the major shareholders of MAPLIGHT THERAPEUTICS INC?

The major shareholders of MAPLIGHT THERAPEUTICS INC (MPLT) by reported 13F value are Novo Holdings A/S, FCPM III SERVICES B.V., T. Rowe Price Investment Management, Inc., Goldman Sachs Group, PRICE T ROWE ASSOCIATES INC /MD/, among 147 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 MPLT」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/MPLT/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →